UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 8, 2006
DULCIN IZMIR CORPORATION
- --------------------------------------------
(Exact name of registrant as specified in its charter)
FLORIDA 20-2710793
- ------------------------------- -------------
(State or other jurisdiction (I.R.S. Employer Identification Number)
of incorporation or organization
6 Hutton Center Drive, Suite 1200
Santa Ana, CA 92707
(Address of principal executive offices) (Zip Code)
Registrant's Telephone number, including area code: (949) 786-2552
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b)
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c)
Item 8.01 Other Events
Dulcin Izmir had entered into a Memorandum of Understanding on August
15, 2005 with Deleo Ltd., a Delaware Corporation. Deloe Ltd owns a
technology called Catalytically Enhanced Engine Fuel Systems. Under the
MOU, Dulcin Izmir was to purchase up to a 70% equity interest in Blue
Sky International, Ltd. Deleo Ltd. has granted Blue Sky an exclusive,
worldwide, non-royalty bearing license to manufacture and market Deleo?s
engine devices. Dulcin Izmir has been unable to successfully complete a
definitive material agreement incorporating the terms of the MOU and
formally terminated further negotiations with Blue Sky on August 18,
2006. As a result, Dulcin Izmir has been actively pursuing alternative
business opportunities.
On September 8, 2006 Dulcin Izmir entered into a Memorandum of
Understanding with Mr. Kevin Fairgrief, of Rancho Mirage, CA whereby
Dulcin Izmir will incorporate and fund a subsidiary named Lifespan
Health Sciences Inc. Fairgrief transferred all of his rights, interest
and knowledge in his treatment program for numerous human diseases and
2
conditions to Lifespan in exchange for 11,000,000 shares of Lifespan.
Dulcin Izmir will fund Lifespan specifically to have Fairgrief?s
treatment programs implemented on a large scale.
Initially Lifespan will create a website and will open a treatment
clinic in Palm Springs, CA, where Fairgrief?s knowledge, experience and
efforts will be tested and documented. Once Lifespan?s program has
been clinically confirmed and treatment protocols have been developed,
Lifespan plans to open other Clinics in California.
After years of testing, Fairgrief?s test results show that many foods
produce different negative reactions in the human body, leading to
diseases of different degrees. Lifespan believes that these foods are
different and unique for everyone, although there are patterns visible
in testing family members. Experience has reflected a wide array of
chronic problems, symptoms and disease that completely resolve once the
offending foods are removed and the body?s digestive tract is allowed
to heal.
Lifespan?s program for treating patients starts with the patient taking
a five pathway serum blood test that will disclose which foods,
additives and beverages cause a negative damaging response from the
immune system. The resulting negative response in most cases is
primarily inflammation. Chronic inflammation, if left untreated, is
what leads to a number of serious conditions. The testing of each
patient allows for a individually tailored program of eating foods that
do not cause harm or affect the body?s complex system in a negative
way. Almost all auto-immune and chronic diseases are relieved when the
patient follows the program which requires the patient to eat from a
specific list of foods, in a 4-5 day rotation to eliminate the chance
of creating new intolerances. There are numerous herbal supplements
added to aid in healing the damaged tissue. There are also other
diagnostics that will allow a thorough treatment depending on each
patient profile and symptoms.
These individual eating and supplement programs require approx four to
six months of careful food and supplement ingestion after which
patients may slowly add new foods back into their diets.
This treatment program has been tested in individuals with diseases
like fibromyalgia, emotional/mood disorders, insomnia, under/over
weight problems, blood pressure and virtually all diseases with an
inflammatory origin. Lifespan believes that by standardizing the
process, it will be able to help a larger amount of patients that
modern traditional medicine to date has been ineffective in treating.
Fairgrief believes that the diseases mentioned above are widespread,
and are a tremendous drain on the world health care system. Dulcin
Izmir thinks there is a significant opportunity to establish a large
network of clinics that can effectively treat these diseases.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Date: October 12, 2006
Dulcin Izmir Corporation
/s/Maria Camila Maz
- ------------------------------
By: Maria Camila Maz, President/CEO